Dr. Brophy’s research has focused on the impact of stress on cellular biology and her current interests are on Holistic Stress Reduction. She has held faculty positions in Surgery, Medicine, Cell Biology and Anatomy, Bioengineering, and Kinesiology. She has been continuously funded by the NIH and the VAMC for over 15 years, has over 90 publications in a broad range of peer reviewed journals, two issued patents, and has received numerous academic awards.
Her research is in the field of the mechanisms of vascular smooth muscle relaxation. Dr. Brophy was a founder of a start-up company, AzERx (Arizona Engineered Therapeutics), and as CEO she brought the Company to acquisition by Orthologic, Inc. (currently Capstone Therapeutics which has completed enrollment in phase II clinical trials).
She is currently Chief Medical Officer and a founder in another biotechnology start up (Moerae Matrix, Inc, MMI). Dr. Brophy has had many firsts as a woman physician including, Professor of Surgery (with tenure) at Vanderbilt, Chair of the Surgical Research Committee for the American College of Surgeons, and Chair of the Bioengineering Technology and Surgical Sciences (BTSS) study section for the NIH. She served as a Commissioner for the State of Arizona (Arizona Biomedical Research Commission). She has two teenage daughters, Jessica (15) and Kate (13).
